 |
autologous peripheral blood T lymphocytes transduced with retroviral vector containing anti CD19 CD28/CD3 zeta chimeric antigen receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse large B-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2014-03-27 00:00:00 |
| Sponsor | Kite Pharma, Inc.;2225 Colorado Avenue;Santa Monica, California, 90404 |
